SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells.

Saved in:
Bibliographic Details
Title: SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells.
Authors: Kontopoulos N; Inserm, CNRS, CRCT (Cancer Research Centre of Toulouse), University of Toulouse, Toulouse, France., Delenclos N; Inserm, CNRS, CRCT (Cancer Research Centre of Toulouse), University of Toulouse, Toulouse, France., Ligat L; Inserm, CNRS, CRCT (Cancer Research Centre of Toulouse), University of Toulouse, Toulouse, France., Top S; NeoVirTech SAS, Toulouse, France., Gallardo F; NeoVirTech SAS, Toulouse, France., Bertagnoli S; University of Toulouse, ENVT, INRAE, IHAP, Toulouse, France., Dusetti N; CNRS, INSERM, CRCM (Cancer Research Centre of Marseille), Institut Paoli-Calmettes, University Aix-Marseille, Marseille, France., Buscail L; Inserm, CNRS, CRCT (Cancer Research Centre of Toulouse), University of Toulouse, Toulouse, France.; Gastroenterology and pancreatology department, Toulouse University Hospital (CHU Toulouse), University of Toulouse, Toulouse, France., Cordelier P; Inserm, CNRS, CRCT (Cancer Research Centre of Toulouse), University of Toulouse, Toulouse, France.; Gastroenterology and pancreatology department, Toulouse University Hospital (CHU Toulouse), University of Toulouse, Toulouse, France.
Source: Human gene therapy [Hum Gene Ther] 2026 Jun; Vol. 37 (11-12), pp. 500-514. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: M.A. Liebert Country of Publication: United States NLM ID: 9008950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7422 (Electronic) Linking ISSN: 10430342 NLM ISO Abbreviation: Hum Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-7422
DOI:10.1177/10430342261441043